Organoarsenic compounds and methods for the treatment of cancer

Details for Australian Patent Application No. 2009282972 (hide)

Owner Ziopharm Oncology, Inc.

Inventors Schwartz, Brian Eric; Lewis, Jonathan; Komarnitsky, Philip B.

Agent Pizzeys

Pub. Number AU-A-2009282972

PCT Pub. Number WO2010/021928

Priority 61/189,511 20.08.08 US

Filing date 14 August 2009

Wipo publication date 25 February 2010

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 31/285 (2006.01)

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/60 (2006.01) - Salicylic acid

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/021928 Priority application(s): WO2010/021928

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282978-Azaindole inhibitors of IAP

2009282963-3and 6-quinolines with N-attached heterocyclic CGRP receptor antagonists